| Profile | GDS4177 / 222104_x_at |
| Title | Imatinib treatment of chronic myeloid leukemia cell lines: KU-812, KCL-22 and JURL-MK1 |
| Organism | Homo sapiens |
| Sample | Title | Value | Rank |
|---|---|---|---|
| GSM603100 | KU-812 Imatinib-treated | 544.21 | 91 |
| GSM603099 | KU-812 non-treated | 548.26 | 90 |
| GSM603098 | KCL-22 Imatinib-treated | 324.36 | 85 |
| GSM603097 | KCL-22 non-treated | 511.99 | 89 |
| GSM603102 | JURL-MK1 Imatinib-treated | 912.89 | 94 |
| GSM603101 | JURL-MK1 non-treated | 761.43 | 93 |